October 14, 2024

Professor Lietzan presents in health policy webinar

On Oct. 8, Professor Erika Lietzan participated in a Hudson Institute webinar entitled, “Do Drug Patents Cause High Prices?” with Professor Adam Mossoff from the Antonin Scalia Law School and Corey Salsberg, vice president and global head of intellectual property affairs for Novartis. They discussed the importance of evidence-based policy… Read More

October 1, 2024

Professor Lietzan Presents at NYU symposium

On Sept. 26-27, Professor Erika Lietzan participated in a symposium at New York University Law School Engelberg Center entitled “Health Care at Reasonable Cost: The Hatch-Waxman Act at 40 and Beyond.”  Sept. 24 marked the 40th anniversary of this statute, which established the modern generic drug approval framework… Read More

August 15, 2024

Professor Lietzan Named to “Best Lawyers in America”

For the 11th straight year, Erika Lietzan, William H. Pittman Professor of Law & Timothy J. Heinsz Professor of Law at Mizzou Law, was named a Best Lawyer in FDA Law and for the 17th straight year as a Best Lawyer in Biotechnology & Life Sciences Law for 2025.

August 13, 2024

Professor Erika Lietzan Reappointed to ACUS

Erika Lietzan, the WIlliam H. Pittman and Timothy J. Heinsz Professor of Law, has been reappointed to a third term as a public member of the Administrative Conference of the United States (ACUS). ACUS is a federal agency charged by Congress with studying the efficiency, adequacy, and fairness of the… Read More

May 29, 2024

Professors Mitchell, Freyermuth and Lietzan win 2024 Mizzou Law Faculty Awards

Each year, three faculty members receive Mizzou Law awards for their outstanding work: one for a scholarly work, one for teaching, and one for the administration of justice. The Husch Blackwell Distinguished Faculty Achievement Award is awarded for teaching excellence, and the recipient is chosen by the Missouri Law Review’s… Read More

May 22, 2024

Professor Lietzan Speaks at Food & Drug Law Institute Annual Meeting

Last week, Professor Erika Lietzan spoke at the Food & Drug Law Institute’s annual meeting. Her talk discussed the Fifth Circuit’s Apter v. HHS decision (which relates to FDA’s famous “you’re not a horse” tweet.) The FDLI is a nonprofit membership organization for specialists in food and drug… Read More

January 16, 2024

Professor Lietzen Fall 2023 Scholarship Recap

In September, Professor Erika Lietzen presented a work in progress at BYU’s law school.  The presentation was called “Accountability By Petition.” She will be submitting the paper – now called “The Power of Petitions” – in the February cycle. The paper explores the role that petitions to federal agencies… Read More

August 30, 2023

Prof. Lietzan named to Best Lawyers List

For the 10th straight year, Erika Lietzan, William H. Pittman Professor of Law & Timothy J. Heinsz Professor of Law at Mizzou Law, was named a Best Lawyer in FDA Law and for the 16th straight year as a Best Lawyer in Biotechnology & Life Sciences Law for 2024.

November 2, 2022

Are Drug Companies the Villain?

For years, brand drug companies have been villainized for “evergreening” or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent — a practice critics say unfairly prevents competition from generic drug companies and that has prompted legislators to consider significant reform to policies that… Read More

September 19, 2022

Prof. Lietzan publishes new paper on why medical device companies rarely renew patents

Professor Erika Lietzan, the William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law at Mizzou Law, recent published a new paper, “The Case of the Missing Device Patents, or: Why Device Patents Matter,” in the Fordham Intellectual Property, Media & Entertainment Law Journal. To read Prof. Read More